Works citing this work

5 works

Work: Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

1. The state of lipid metabolism in patients with diabetic nephropathy

   Lola Daminova, Sitora Muminova, Bakhodir Nigmonov

   ArticleLiver Disease Diagnosis and TreatmentArchives of Gerontology and Geriatrics Plus20240 citations

   ABIABI:AkademIndex/openalex/2024.article.008680

2. Advancements in risk stratification and management strategies in primary cardiovascular prevention

   Fotios Barkas, Yusuf Ziya Şener, Pelin Golforoush +25

   Review articleLipoproteins and Cardiovascular HealthAtherosclerosis20240 citations

   ABIABI:AkademIndex/openalex/2024.review-article.000004

3. Duration of the hypolipidemic effect after the course of intravenous laser therapy in patients with lipid metabolism disorders

   A. A. Achilov, S. V. Gornov, D. U. Usmonzoda +5

   ArticleLaser Applications in Dentistry and MedicineLaser Medicine20250 citations

   ABIABI:AkademIndex/openalex/2025.article.016750

4. Meta Analysis of <scp>DHA</scp> and <scp>EPA</scp> Supplementation on Cardiovascular Outcomes and Atrial Fibrillation Risk

   Sepideh Karkon Shayan, Rosull Saadoon Abbood, Sarah F. Al‐Taie +10

   ArticleFatty Acid Research and HealthPharmacology Research & Perspectives20260 citations

   ABIABI:AkademIndex/openalex/2026.article.018570

5. Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics

   Christian Bork, Børge G. Nordestgaard, Berit Storgaard Hedegaard +67

   ArticleLipoproteins and Cardiovascular HealthAtherosclerosis20260 citations

   ABIABI:AkademIndex/openalex/2026.article.020412